Wei-Li Ma

6PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.

|Dec 03, 2025
Acquired MYC rearrangement potentially associated with ibrutinib resistance in mantle cell lymphoma.

Chang-Tsu Yuan, Li-Yu Sun, Chieh-Lung Cheng

|Dec 27, 2023
Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era.

Wei-Li Ma, Ruey-Long Hong, Pei-Jen Lou

|Jan 05, 2023
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.

Chieh-Lung Cheng, Po-Ting Yeh, Wei-Quan Fang

|Oct 10, 2022
Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices.

Wei-Li Ma, Dwan-Ying Chang, Ching-Hung Lin

|Mar 29, 2022
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.

Wei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu

Pageof 1

Frequent Collaborators

1 joint publications

Ching-Hung Lin

1 joint publications

Yen-Shen Lu

1 joint publications

Chieh-Lung Cheng

1 joint publications

Po-Ting Yeh